Nautilus Biotechnology Inc
NAUT
Get informed when a big investor buys or sells
+ FollowMarket Cap$112.71M
Close$
$-0.14
115.4% downside
Current Fair Value
115.4% downsideOvervalued by 115.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $112.71 Million |
|---|---|
| Enterprise Value | $127.36 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.87 |
| Outstanding Shares | 126,886,646 |
Return
| Return on Equity | -43.11% |
|---|---|
| Return on Assets | -34.55% |
| Return on Invested Capital | -38.24% |
Valuation & Multiples
| P/E Ratio | -1.97 |
|---|---|
| PEG | 52.46 |
| Price to Sales | - |
| Price to Book Ratio | 0.9 |
| Enterprise Value to Revenue | 670.32 |
| Enterprise Value to EBIT | -2.15 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$250,000
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$200,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 61,700▲ Infinity% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 42.91%▼ 3.26% |
|---|---|
| Total Invested | $210.83M▲ 85.47% |
| Investors Holding | 81▲ 15.00% |
ESG Score
No data